Literature DB >> 27262620

Computational predictions suggest that structural similarity in viral polymerases may lead to comparable allosteric binding sites.

Jodian A Brown1, Marie V Espiritu1, Joel Abraham1, Ian F Thorpe2.   

Abstract

The identification of ligand-binding sites is often the first step in drug targeting and design. To date there are numerous computational tools available to predict ligand binding sites. These tools can guide or mitigate the need for experimental methods to identify binding sites, which often require significant resources and time. Here, we evaluate four ligand-binding site predictor (LBSP) tools for their ability to predict allosteric sites within the Hepatitis C Virus (HCV) polymerase. Our results show that the LISE LBSP is able to identify all three target allosteric sites within the HCV polymerase as well as a known allosteric site in the Coxsackievirus polymerase. LISE was then employed to identify novel binding sites within the polymerases of the Dengue, West Nile, and Foot-and-mouth Disease viruses. Our results suggest that all three viral polymerases have putative sites that share structural or chemical similarities with allosteric pockets of the HCV polymerase. Thus, these binding locations may represent an evolutionarily conserved structural feature of several viral polymerases that could be exploited for the development of small molecule therapeutics.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allosteric inhibition; Allosteric site; Ligand binding site predictor; Viral polymerase

Mesh:

Substances:

Year:  2016        PMID: 27262620      PMCID: PMC4969206          DOI: 10.1016/j.virusres.2016.05.029

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  61 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design.

Authors:  Fumiaki Yokokawa; Shahul Nilar; Christian G Noble; Siew Pheng Lim; Ranga Rao; Stefani Tania; Gang Wang; Gladys Lee; Jürg Hunziker; Ratna Karuna; Ujjini Manjunatha; Pei-Yong Shi; Paul W Smith
Journal:  J Med Chem       Date:  2016-04-08       Impact factor: 7.446

Review 3.  The dengue vaccine pipeline: Implications for the future of dengue control.

Authors:  Lauren M Schwartz; M Elizabeth Halloran; Anna P Durbin; Ira M Longini
Journal:  Vaccine       Date:  2015-05-16       Impact factor: 3.641

4.  Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5.

Authors:  Hélène Malet; Marie-Pierre Egloff; Barbara Selisko; Rebecca E Butcher; Peter J Wright; Michael Roberts; Arnaud Gruez; Gerlind Sulzenbacher; Clemens Vonrhein; Gérard Bricogne; Jason M Mackenzie; Alexander A Khromykh; Andrew D Davidson; Bruno Canard
Journal:  J Biol Chem       Date:  2007-02-07       Impact factor: 5.157

5.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

Review 6.  Strategies for development of Dengue virus inhibitors.

Authors:  Christian G Noble; Yen-Liang Chen; Hongping Dong; Feng Gu; Siew Pheng Lim; Wouter Schul; Qing-Yin Wang; Pei-Yong Shi
Journal:  Antiviral Res       Date:  2010-01-08       Impact factor: 5.970

Review 7.  Foot-and-mouth disease virus.

Authors:  Esteban Domingo; Eric Baranowski; Cristina Escarmís; Francisco Sobrino
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2002-10       Impact factor: 2.268

8.  Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.

Authors:  Hui Li; John Tatlock; Angelica Linton; Javier Gonzalez; Tanya Jewell; Leena Patel; Sarah Ludlum; Matthew Drowns; Sadayappan V Rahavendran; Heather Skor; Robert Hunter; Stephanie T Shi; Koleen J Herlihy; Hans Parge; Michael Hickey; Xiu Yu; Fannie Chau; Jim Nonomiya; Cristina Lewis
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 8.039

9.  Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase.

Authors:  Brittny C Davis; Ian F Thorpe
Journal:  Proteins       Date:  2012-09-15

Review 10.  Vaccines in development against West Nile virus.

Authors:  Samantha Brandler; Frederic Tangy
Journal:  Viruses       Date:  2013-09-30       Impact factor: 5.048

View more
  1 in total

1.  Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase.

Authors:  Sanjay Kumar; Leena H Bajrai; Arwa A Faizo; Aiah M Khateb; Areej A Alkhaldy; Rashmi Rana; Esam I Azhar; Vivek Dhar Dwivedi
Journal:  Viruses       Date:  2022-08-20       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.